Amedisys, Inc. (NASDAQ:AMED – Get Free Report) has earned a consensus recommendation of “Hold” from the eleven analysts that are presently covering the firm, Marketbeat reports. Nine research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month price objective among brokers that […]